There is strong evidence that the immune system changes dramatically during pregnancy in order to prevent the developing fetus from being ''attacked" by the maternal immune system. Due to these alterations in peripheral immune function, many women that suffer from autoimmune disorders actually find significant relief from their symptoms throughout pregnancy; however, these changes can also leave the mother more susceptible to infections that would otherwise be mitigated by the inflammatory response (Robinson and Klein, 2012). Only one other study has looked at changes in microglial number and morphology during pregnancy and the postpartum period (Haim et al., 2016), but no one has yet examined the neuroimmune response following an immune challenge during this time. Therefore, in this study, we investigated the impact of an immune challenge during various time-points throughout pregnancy and the postpartum period on the expression of immune molecules in the brain of the mother and fetus. Our results indicate that similar to the peripheral immune suppression measured during pregnancy, we also see significant suppression of the immune response in the maternal brain, particularly during late gestation. In contrast to the peripheral immune system, immune modulation in the maternal brain extends moderately into the postpartum period. Additionally, we found that the fetal immune response in the brain and placenta is also suppressed just before parturition, suggesting that cytokine production in the fetus and placenta are mirroring the peripheral cytokine response of the mother.
Introduction
It is well known that the peripheral immune system changes dramatically during pregnancy in order to prevent the developing fetus from being attacked by the maternal immune system. Many studies have demonstrated that this is the consequence of a transient suppression of maternal cell-mediated immunity against the semi-allogenic fetus during pregnancy (Mellor et al., 2001; Raghupathy, 1997; Trowsdale and Betz, 2006) . For most women, these changes in peripheral immune function go unnoticed; however, when this shift in immune function is coupled with sickness, or a pre-existing health condition, many women experience a significant change in their health. For example, many women find relief from pre-existing autoimmune disorders during pregnancy. In 1938, Hench was the first to report that pregnancy could ameliorate the symptoms of rheumatoid arthritis. In these cases, patients reported significant improvement of symptoms during their pregnancy, particularly later in gestation, and a significant worsening of symptoms in the weeks after giving birth (Hazes et al., 2011; Hench, 1938; Nelson and Ostensen, 1997) . Similar findings have also been reported for women diagnosed with the autoimmune disease multiple sclerosis (MS). These women have significantly reduced rates of MS relapse during pregnancy, and a significant increase in relapse rates in the first three months postpartum (Bernardi et al., 1991; Confavreux et al., 1998) . Similarly, late pregnancy is also associated with an increased severity and mortality associated with a number of infections, both viral and bacterial (Robinson and Klein, 2012) , such that these effects of pregnancy on peripheral immune function directly contribute to an overall female susceptibility to disease. The effects of pregnancy on disease susceptibility are a direct result of suppression or modulation of specific immune molecules that likely underlie the disease's progression or remission. Taken together, this evidence indicates that pregnancy induces significant modulation of the mother's peripheral immune system and has substantial consequences for her physical health.
It is also known that immune dysregulation is often linked to the onset of certain mental health disorders, including depression and anxiety (Raison and Miller, 2017; Remus and Dantzer, 2016) . The peripartum period is a critical time-point in a woman's life that is associated with an increased risk of certain mental health
